Regaining compliance with Nasdaq is a significant positive development for BioSig Technologies. It removes the risk of delisting, which can severely affect a company's stock price and its ability to raise capital. This news directly impacts investor confidence and the company's stock market performance, likely leading to a short-term increase in its stock price.